Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Tg Therapeuticscmn (TGTX)

Tg Therapeuticscmn (TGTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 833,873
  • Shares Outstanding, K 145,274
  • Annual Sales, $ 6,690 K
  • Annual Income, $ -348,100 K
  • 60-Month Beta 2.19
  • Price/Sales 132.26
  • Price/Cash Flow N/A
  • Price/Book 6.82
Trade TGTX with:

Options Overview Details

View History
  • Implied Volatility 103.63% ( -17.48%)
  • Historical Volatility 101.34%
  • IV Percentile 40%
  • IV Rank 47.11%
  • IV High 156.88% on 04/13/22
  • IV Low 56.21% on 11/05/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 177
  • Volume Avg (30-Day) 1,932
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 178,949
  • Open Int (30-Day) 178,961

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.34
  • Number of Estimates 5
  • High Estimate -0.19
  • Low Estimate -0.47
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +47.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.55 +4.95%
on 09/23/22
7.74 -24.74%
on 09/12/22
-0.94 (-13.83%)
since 08/26/22
3-Month
3.96 +47.10%
on 06/28/22
8.65 -32.66%
on 08/15/22
+1.42 (+32.39%)
since 06/24/22
52-Week
3.48 +67.39%
on 06/16/22
35.94 -83.79%
on 11/08/21
-26.33 (-81.89%)
since 09/24/21

Most Recent Stories

More News
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TG Therapeutics, Inc....

TGTX : 5.79 (+0.87%)
Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds TG Therapeutics, Inc. (TGTX) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the “Company”) (NASDAQ:...

TGTX : 5.79 (+0.87%)
TGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ:...

TGTX : 5.79 (+0.87%)
TGTX DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Friday Deadline in Securities Class Action - TGTX

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between...

TGTX : 5.79 (+0.87%)
TGTX LAWSUIT ALERT: Levi & Korsinsky Notifies TG Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (NASDAQ: TGTX) of a class action...

TGTX : 5.79 (+0.87%)
TG THERAPEUTICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc. (“TG Therapeutics” or the...

TGTX : 5.79 (+0.87%)
TGTX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 16, 2022 in the Class Action Filed on Behalf of TG Therapeutics, Inc. Shareholders

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ: TGTX)...

TGTX : 5.79 (+0.87%)
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind TG Therapeutics Investors of a Lead Plaintiff Deadline of September 16, 2022

/PRNewswire/ -- Attention TG Therapeutics, Inc. ("TG Therapeutics") (NASDAQ: TGTX) shareholders: The Law Offices of Vincent Wong announce that a class action...

TGTX : 5.79 (+0.87%)
TGTX SHAREHOLDER ALERT: Jakubowitz Law Reminds TG Therapeutics Shareholders of a Lead Plaintiff Deadline of September 16, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of TG Therapeutics, Inc. (NASDAQ:...

TGTX : 5.79 (+0.87%)
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between...

TGTX : 5.79 (+0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various...

See More

Key Turning Points

3rd Resistance Point 6.56
2nd Resistance Point 6.32
1st Resistance Point 6.03
Last Price 5.79
1st Support Level 5.50
2nd Support Level 5.26
3rd Support Level 4.97

See More

52-Week High 35.94
Fibonacci 61.8% 23.54
Fibonacci 50% 19.71
Fibonacci 38.2% 15.88
Last Price 5.79
52-Week Low 3.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar